Use of Serum Alkaline Phosphatase Levels as Biomarkers in Rheumatoid Arthritis patients: A Hospital Based Study

  • Pervaind Kumar Sharma Associate Professor , Dept. of Orthopaedics, F .H. Medical College Etmadpur, Agra
Keywords: Rheumatoid Arthritis, systematic inflammatory disorder, osteoblasts, osteoclasts

Abstract

Background: Rheumatoid Arthritis (RA) is a chronic systematic inflammatory disorder . It may affect many tissue and organs, mainly joints. This process is based on imbalance between bone resorbing osteoclasts and bone forming osteoclasts. The main cause of this imbalance is enhance expression of inflammatory cytokines, such as tumour necrosis factor (TNF). Methods: A study was conducted  in the Dept. of Orthopaedics, F.H. Medical College Etmadpur, Agra.

Results: Total 304 patients were included in this study, in which 152 control and 152 cases included in this study. Out of the 152 control, 54 were male and 98 were female. In the control patients most of the people were belong to 51-60 age group. In the 152 Rheumatoid arthritis cases, 44 were male and 108 were female. In the Rheumatoid arthritis cases most of the people belong to 51-60 age grouping. Conclusion: The results of this study shows a significant increase in serum alkaline phosphatase level compared to controls which confirm the association of serum alkaline phosphatase with Rheumatoid arthritis.

 

Downloads

Download data is not yet available.

References

1. Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Stach C, Schett G. Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion. Ann Rheum Dis 2011;70(9):1587-93.
2. Stach CM, Bauerle M, Englbrecht M, Kronke G, Engelke K, Manger B, Schett G. Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high resolution computedtomography.Arthritis Rheum2010;62(2):330-9.
3. Rosenberg AE. Bones, Joints and Soft tissue tumor. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran Pathological Basis of Diseases. 8th ed. India: Elsevier; 2012;1237-40.
4. Carrasco R, Barton A. Biomarkers of outcome in Rheumatoid Arthritis. Rheumatology Reports 2010;2(1):2-38.
5. Bowers GN Jr, McComb RB. Measurment of total alkaline phosphatase activity in human serum. ClinChem1975;21(13):1988-95.
6. Najeeb Q, Aziz R. Comparison of Alkaline phosphatase, Lactate Dehydrogenase and Acid Phosphatase Levels in Serum and Synovial Fluid between Patients with Rheumatoid Arthritis and Osteoarthritis. International Journal of Science and Research 2015;4(4):1069-72.
7. Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled study. Arthritis Res Ther [1478- 6354]. 2006; 8(3): [7]. Accessed: Sept 24, 2015. Available from: http://www.arthritis-research.com/content/8/3/R82.
8. Magaro M, Altomonte L, Mirone L, Zoli A, Corvino G. Bone gla protein levels and bone turnover in rheumatoid arthritis. Br J Rheumatol 1989;28(3):207-11.
9. Aschenberg S, Finzel S, Schmidt s, Kraus S, Engelke K, Englbrecht M, et al. Catabolic and anabolic periarticular bone changes in patients with rheumatoid arthritis: a computed tomography study on the role of age, disease duration and bone markers. Arthritis Res Ther [1478-6354]. 2013;15(3):[6]. Accessed September 24, 2015. Available at: http://www.arthritis-research.com/content/15/3/R62.
10. Vaithialingam A, Lakshmi TM, Suryaprakash G, Edukondalu AD, Reddy EP. Alkaline Phosphatase levels in Rheumatoid Arthritis and Osteoporosis in clinical practice. Journal of Current Trends in Clinical Medicine & Laboratory Biochemistry 2013;1(2):20-23.
11. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis and Rheumatism 2006;54(1):38-46.
12. Jacobs JWG, De Nijs RNJ, Lems WF, Bijlsma JWJ. Bone metabolism in rheumatoid arthritis. ClinExp Rheumatol 2000;18(Suppl 21):S5-11.
13. Gheita T, Fawzy S, Rizk A, Hussein H. Impaired bone formation and osteoporosis in postmenopausal elderly onset rheumatoid arthritis patients. The Egyptian Rheumatologist 2011;33(3):155-62.
14. Weisman MH, Orth RW, Catherwood BD, Manolgas SC, Deftos LJ. Measure of bone loss in Rheumatoid arthritis. Arch Intern 1986:146(4):701-4.
15. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344(8914):23-7.
16. Gough A, Sambrook P, Devlin J,Huissoon A, Njeh C, Robbins S, et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol1998;25(7):1282-9.
17. Shenstone BD, Mahmoud A, Woodward R, Elvins D, Palmer R, Ring EF, Bhalla AK. Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol1994;33(6):541-5.
Published
2018-06-28
How to Cite
1.
Sharma P. Use of Serum Alkaline Phosphatase Levels as Biomarkers in Rheumatoid Arthritis patients: A Hospital Based Study. IABCR [Internet]. 28Jun.2018 [cited 21Nov.2018];4(2):125-7. Available from: https://iabcr.org/index.php/iabcr/article/view/359